A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Massachusetts General Hospital
City of Hope Medical Center
Northside Hospital, Inc.